参考文献/References:
[1] SHIN J A, LEE J H, LIM S Y, et al. Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness[J]. Journal of Diabetes Investigation, 2013, 4(4): 334-343.
[2] XU Tao, LIU Junting, LIU Junxiu, et al. Relation between metabolic syndrome and body compositions among Chinese adolescents and adults from a large-scale population survey [J]. BMC Public Health, 2017, 17(1): 337.
[3] ITO R, NARITA S, HUANG Mingguo, et al. The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the “obesity paradox”[J]. PLoS One, 2017, 12(2): e0171615.
[4] 刘运端,林世恒.脂联素及其基因多态性与广西瑶族冠心病的关系[J].现代检验医学杂志,2015,30(4):56-59.
LIU Yunduan,LIN Shiheng.Study on relations between adiponectin and its gene polymorphism and Yao Coronary heart disease of Guangxi district[J].J Mod Lab Med,2015,30(4):56-59.
[5] 宋静,彭素芳.妊娠糖尿病患者血清脂联素与炎症因子的关系及临床意义[J].现代检验医学杂志,2011,26(3):139-140,143.
SONG Jing,PENG Sufang.Clinical significance and relationship of serum adiponectin with inflammatory factors in gestational diabetes mellitus[J].J Mod Lab Med,2011,26(3):139-140,143.
[6] FLYNN C, BAKRIS G L. Interaction between adiponectin and aldosterone[J]. Cardiorenal Medicine, 2011, 1(2): 96-101.
[7] 中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中国实用乡村医生杂志,2012,19(18):5-15.
Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults [J].Chinese Practical Journal of Rural Doctor,2012,19(18):5-15.
[8] LI Ri, LI Wenchen, LUN Zhijun, et al. Prevalence of metabolic syndrome in mainland China: a meta-analysis of published studies [J]. BMC Public Health, 2016, 16: 296.
[9] YAN Ruohua, LI Wei, YIN Lu, et al. Cardiovascular diseases and risk-factor burden in urban and rural communities in high-, middle-, and low-income regions of China: a large community-based epidemiological study[J]. Journal of the American Heart Association, 2017,6(2)e004445.
[10] PARKER-DUFFEN J L, WALSH K. Cardiometabolic effects of adiponectin[J]. Best Practice & Research Clinical Endocrinology & Metabolism, 2014, 28(1): 81-91.
[11] HOUSHMAND-OEREGAARD A, HANSEN N S, HJORT L, et al. Differential adipokine DNA methylation and gene expression in subcutaneous adipose tissue from adult offspring of women with diabetes in pregnancy [J]. Clinical Epigenetics, 2017, 9: 37.
[12] CHO S A, JOO H J, CHO J Y, et al. Visceral fat area and serum adiponectin level predict the development of metabolic syndrome in a Community-Based asymptomatic population[J]. PLoS One, 2017, 12(1): e0169289.
[13] KANG D R, YADAV D, KOH S B, et al. Impact of serum leptin to adiponectin ratio on regression of metabolic syndrome in High-Risk individuals: the ARIRANG study[J]. Yonsei Medical Journal, 2017, 58(2): 339-346.
[14] KIM J Y, AHN S V, YOON J H, et al. Prospective study of serum adiponectin and incident metabolic syndrome the ARIRANG study[J]. Diabetes Care, 2013, 36(6): 1547-1553.
[15] YUAN Huiping, SUN Liang, LI Xinghui, et al. Association of adiponectin polymorphism with metabolic syndrome risk and adiponectin level with stroke risk: a meta-analysis[J]. Scientific Reports, 2016, 6: 31945.
[16] ZHAO Na, LI Ningxia, ZHANG Shengjun, et al. Associations between two common single nucleotide polymorphisms(rs2241766 and rs1501299)of ADIPOQ gene and coronary artery disease in type 2 diabetic patients: a systematic review and meta-analysis[J]. Oncotarget, 2017, 8(31): 51994-52005.
[17] PETERS K E, BEILBY J, CADBY G, et al. A comprehensive investigation of variants in genes encoding adiponectin(ADIPOQ)and its receptors(ADIPOR1/R2), and their association with serum adiponectin, type 2 diabetes, insulin resistance and the metabolic syndrome[J]. BMC Medical Genetics, 2013, 14: 15.
[18] 毛维维,伊桂叶.不同肥胖类型患者血清代谢指标与内脏脂肪指数的相关性分析[J].现代检验医学杂志,2019,34(5):1-3,8.
MAO Weiwei, YI Guiye. Correlation between serum metabolic indexes of different obesity types and visceral adiposity index[J]. Journal of Modern Laboratory Medicine, 2019,34(5):1-3,8.
[19] 顾进,侯思南,许海英.中性粒细胞淋巴细胞比率在衡量肥胖病人炎症状态的初步探讨[J].现代检验医学杂志,2016,31(6):147-149.
GU Jin,HOU Sinan,XU Haiying.Preliminary study on neutrophil-lymphocyte ratio as an indicator of inflammatory state in obese patients[J]. Journal of Modern Laboratory Medicine,2016,31(6):147-149.
相似文献/References:
[1]张养民,薛飞肖.白细胞介素6-174C/G及-572C/G基因多态性与高血压相关性meta分析[J].现代检验医学杂志,2016,31(01):33.[doi:10.3969/j.issn.1671-7414.2016.01.009]
ZHANG Yang-min,XUE Fei-xiao.Association of Interleukin-6 Gene -174C/G and -572C/G
Polymorphisms with Hypertension:A Meta-Analysis[J].Journal of Modern Laboratory Medicine,2016,31(01):33.[doi:10.3969/j.issn.1671-7414.2016.01.009]
[2]赵 佳a,左 林b,姚创利a,等.锰超氧化物歧化酶基因变异
与血脂和同型半胱氨酸水平的关系研究[J].现代检验医学杂志,2016,31(03):12.[doi:10.3969/j.issn.1671-7414.2016.03.004]
ZHAO Jiaa,ZUO Linb,YAO Chuang-lia,et al.Study on the Relationship between Manganese Superoxide Dismutase
Gene Variants and the Levels of Blood Lipid and Homocysteine[J].Journal of Modern Laboratory Medicine,2016,31(01):12.[doi:10.3969/j.issn.1671-7414.2016.03.004]
[3]韩瑞玲,李 艳,吴 薇.武汉地区冠心病患者氯吡格雷药物代谢相关基因CYP2C19的多态性分布分析[J].现代检验医学杂志,2015,30(03):21.[doi:10.3969/j.issn.1671-7414.2015.03.006]
HAN Rui-ling,LI Yan,WU Wei.Analysis of the Polymorphism Distribution of Clopidogrel Metabolism
Related Gene CYP2C19 in Patients with Coronary Artery Disease in Wuhan[J].Journal of Modern Laboratory Medicine,2015,30(01):21.[doi:10.3969/j.issn.1671-7414.2015.03.006]
[4]王欣俞,王德辉,刘淑娟,等.中国汉族人群CYP2C9和VKORC1基因多态性对华法林用药的影响[J].现代检验医学杂志,2015,30(04):28.[doi:10.3969/j.issn.1671-7414.2015.04.007]
[5]姚创利a,赵 佳a,黎 阳a,等.锰超氧化物歧化酶9 Ala/Val基因多态性对冠心病的影响[J].现代检验医学杂志,2015,30(02):1.[doi:10.3969/j.issn.1671-7414.2015.02.001]
YAO Chuang-lia,ZHAO Jiaa,LI Yanga,et al.Effects of Manganese Superoxide Dismutase 9 Ala/Val
Genetic Polymorphisms on Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2015,30(01):1.[doi:10.3969/j.issn.1671-7414.2015.02.001]
[6]熊 娟,丁 园,张 敬,等.XRCC2基因R188H位点多态性与大肠癌易感性的Meta分析[J].现代检验医学杂志,2016,31(04):70.[doi:10.3969/j.issn.16717-414.2016.04.018]
XIONG Juan,DING Yuan,ZHANG Jing,et al.Association between XRCC2 R188H Polymorphism
and Risk of Colorectal Cancer:A Meta-Analysis[J].Journal of Modern Laboratory Medicine,2016,31(01):70.[doi:10.3969/j.issn.16717-414.2016.04.018]
[7]陈建国.结直肠癌患者FOLFOX化疗与GSTP1,XRCC1基因多态性的研究[J].现代检验医学杂志,2016,31(05):66.[doi:10.3969/j.issn.1671-7414.2016.05.017]
CHEN Jian-guo.Relationship between FOLFOX Chemotherapy of Colorectal Cancer
Patients and GSTP1,XRCC1 Gene Polymorphism[J].Journal of Modern Laboratory Medicine,2016,31(01):66.[doi:10.3969/j.issn.1671-7414.2016.05.017]
[8]姚创利,赵 佳,鲁旭娟,等.冠心病患者血清脂蛋白相关磷脂酶A2水平与锰超氧化物歧化酶9 Ala/Val基因多态性关系探讨[J].现代检验医学杂志,2017,32(01):26.[doi:10.3969/j.issn.1671-7414.2017.01.008]
YAO Chuang-li,ZHAO Ja,LU Xu-juan,et al.Study on the Relationship between Lipoprotein Associated
Phospholipase A2 Level and Manganese Superoxide Dismutase 9 Ala/Val
Genetic Polymorphism in Patients with Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2017,32(01):26.[doi:10.3969/j.issn.1671-7414.2017.01.008]
[9]陈 文,朱旭明.血管紧张素转化酶插入/缺失基因多态性与抗高血压药疗效关系的meta分析[J].现代检验医学杂志,2017,32(02):67.[doi:10.3969/j.issn.1671-7414.2017.02.018]
CHEN Wen,ZHU Xu-ming.Association of Polymorphism
in Angiotensin Converting Enzyme Insertion/Deletion Gene
with Curative Effect of Hypotensive Drugs:A Meta Analysis[J].Journal of Modern Laboratory Medicine,2017,32(01):67.[doi:10.3969/j.issn.1671-7414.2017.02.018]
[10]张宝华a,武 琪b.Nrf2基因启动子rs35652124,rs6706649和rs6721961位点单核苷酸多态性与阿尔茨海默病的相关性研究[J].现代检验医学杂志,2017,32(05):62.[doi:10.3969/j.issn.1671-7414.2017.05.017]
ZHANG Bao-huaa,WU Qib.Association between Nrf2 Gene rs35652124,rs6706649
and rs6721961 Polymorphism and Alzheimer's Disease[J].Journal of Modern Laboratory Medicine,2017,32(01):62.[doi:10.3969/j.issn.1671-7414.2017.05.017]
[11]刘运端,林世恒.脂联素及其基因多态性与广西瑶族冠心病的关系[J].现代检验医学杂志,2015,30(04):56.[doi:10.3969/j.issn.1671-7414.2015.04.015]
LIU Yun-duan,LIN Shi-heng.Study on Relations between Adiponectin and Its Gene
Polymorphism and Yao Coronary Heart Disease of Guangxi District[J].Journal of Modern Laboratory Medicine,2015,30(01):56.[doi:10.3969/j.issn.1671-7414.2015.04.015]